E, L., JH, L., HR, K., SJ, H., S, L., SY, O., . . . H, L. (2026). Infectious complications after CAR T-cell therapy: Mechanisms, risk stratification, and prevention. Blood research, 61(1), . https://doi.org/10.1007/s44313-026-00145-2
Chicago Style (17th ed.) CitationE, Lee, Lee JH, Kim HR, Huh SJ, Lee S, Oh SY, Kim SH, and Lee H. "Infectious Complications After CAR T-cell Therapy: Mechanisms, Risk Stratification, and Prevention." Blood Research 61, no. 1 (2026). https://doi.org/10.1007/s44313-026-00145-2.
MLA (9th ed.) CitationE, Lee, et al. "Infectious Complications After CAR T-cell Therapy: Mechanisms, Risk Stratification, and Prevention." Blood Research, vol. 61, no. 1, 2026, https://doi.org/10.1007/s44313-026-00145-2.
Warning: These citations may not always be 100% accurate.